Jenburkt Pharmaceuticals has scheduled its 41st Annual General Meeting (AGM) for September 4, 2026, at 3:30 p.m.

IST, to be held via video conferencing.

The company has already sent the Annual Report and AGM notice to members.

Shareholders can cast their votes remotely, with e-voting opening on September 1, 2026, at 9:00 a.m.

IST and closing on September 3, 2026, at 5:00 p.m.

IST.

The eligibility cut-off date for voting is August 28, 2026. This is crucial for investors to participate in company governance and decisions.